FDA approves new overactive bladder drug

Published: Nov. 3, 2008 at 11:04 AM
Order reprints
WASHINGTON, Nov. 3 (UPI) -- The U.S. Food and Drug Administration said it has approved a new drug -- Toviza -- to help patients suffering from an overactive bladder.

The federal agency said Toviaz (fesoterodine fumarate) works by relaxing the smooth muscle tissue of the bladder, thus reducing urinary frequency, the urge to urinate and sudden urinary incontinence -- all characteristic symptoms of an overactive bladder.

"Patients who suffer from overactive bladder face quality of life issues that can hamper their ability to enjoy life to its fullest," said Dr. George Benson, deputy director of the Division of Reproductive and Urologic Products at the FDA's Center for Drug Evaluation and Research. "This new drug will provide an additional treatment option to help them manage problems with an overactive bladder."

Toviaz is manufactured by Schwarz Pharma of Zwickau, Germany, and is distributed in the United States by Pfizer Inc. (NYSE:PFE) of New York.


© 2008 United Press International, Inc. All Rights Reserved.



The almanac (3 min)
Logano holds on for Nationwide win
MLB: Texas 6, Seattle 4
MLB: Atlanta 4, Colorado 1
MLB: LA Angels 10, N.Y. Yankees 6
Man charged with blasting porn soundtrack
NOAA: El Nino developing in Pacific
fark
It's the 21st Century - Photoshop your own flying car
A kid had to be rescued from a mall escalator. You know the rescue wasn't that dramatic. When an...
Not news: Police spokesman sends out mugshot to a TV station. News: It was the wrong photo. Fark:...
Emergency evacuation of 747, pants before or after noxious odor spilled into cabin
Iran condemns Italy for "violent suppression of justice-seeking protesters by the Italian police"...
Only the Royals would consider Yuniesky Betancourt a 'major trade'. Second paragraph- 'Betancourt,...